Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Orthobiologics Market by Product, Application, End-user and Geography - Forecast to 2024 - ResearchAndMarkets.com

April 8, 2019

DUBLIN--(BUSINESS WIRE)--Apr 8, 2019--The “Global Orthobiologics Market - Segmented by Product, Application, End User, and Geography - Growth, Trends, and Forecast (2019 - 2024)” report has been added to ResearchAndMarkets.com’s offering.

The orthobiologics market is projected to register a CAGR of about 5.4% during the forecast period.

Increasing Patient Preference for Minimally Invasive Procedures

Orthobiologic therapy is a minimally invasive therapy and one of the components of regenerative medicine that are used to treat several musculoskeletal ailments, including degenerative osteoarthritis. Lately, orthobiologics have come to be known as one of the prominent treatment option for early osteoarthritis (OA) of the knee.

The interests about orthobiologcs in the medical community and growing research in the field of regenerative medicine, coupled with promising clinical results from the use of orthobiologics are helping to make the clinical applications of this treatment more diverse every day. Biological therapy or cellular arthroplasty is evolving rapidly in the management of OA.

Repair of damaged cartilage and biological restitution can be possible by the judicious use of autologous biological products. This will help the orthobiologics market to flourish during the forecast period.

High Cost Associated with Orthobiologics-Based Treatments

Treatments involving orthobiologics are expensive and often not covered by the governments. This is owing to the fact that this form of treatment is relatively new and there have not been enough studies to prove their efficacy and effectiveness in treating the patients.

Also, the possibility of alternative form of treatments mean that patients who are skeptical about this form of treatment can opt for other alternative treatments available. This will lead to the slowdown of the growth of this market.

North America to Maintain Lead in the Orthobiologics Market

North America is expected to command the largest share of the market in 2017 due to the increasing incidence of spinal disorders, rising geriatric and obese population, growing preference for minimally invasive procedures, and growing physician and patient awareness about newly introduced treatment procedures and technologies.

However, Asia Pacific is expected to register the highest growth rate during the forecast period. The presence of a large geriatric and target patient population, high incidence of osteoarthritis and obesity, increasing government spending on healthcare, and improving healthcare infrastructure are some of the major factors driving the growth of the Asia Pacific orthobiologics market.

Major Players

  • Arthrex Inc.
  • Bioventus LLC
  • Depuy Synthes (A Subsidiary of Johnson & Johnson)
  • Globus Medical Inc.
  • Harvest Technologies Corporation (A Terumo BCT Company)
  • K2M Group Holdings Inc.
  • Kuros Biosciences Ltd.
  • Medtronic PLC
  • Nuvasive Inc.
  • Orthofix International N.V.
  • RTI Surgical Inc.
  • Seaspine Holdings Corporation

Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

5.1 Current Market Scenario

5.2 Porter’s Five Forces Analysis

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

6.1 Market Drivers

6.1.1 Increasing Incidence of Sports Injuries and Road Accidents

6.1.2 Increasing Incidence of Osteoarthritis

6.1.3 Rising Geriatric and Obese Population

6.1.4 Increasing Patient Preference for Minimally Invasive Procedures

6.2 Market Restraint

6.2.1 High Costs Associated With Orthobiologics-based Treatments

6.2.2 Preference for Alternative Treatment Options

6.3 Market Opportunities

6.4 Market Key Challenges

7. Market Segmentation

7.1 Market By Product

7.1.1 Viscosupplementation Products

7.1.2 Demineralized Bone Matrices

7.1.3 Synthetic Orthobiologics

7.1.4 Bone Morphogenic Protein

7.1.5 Allografts

7.1.6 Plasma-rich Protein

7.1.7 Bone Marrow Aspirate Concentrate

7.2 Market By Application

7.2.1 Osteoarthritis and Degenerative Arthritis

7.2.2 Spinal Fusion

7.2.3 Soft-tissue Injuries

7.2.4 Fracture Recovery

7.2.5 Maxillofacial and Dental Applications

7.3 Market By End User

7.3.1 Hospitals, Orthopedic Clinics, and Ambulatory Care Centers

7.3.2 Research and Academic Institutes

7.3.3 Dental Clinics and Facilities

7.4 Market By Geography

7.4.1 North America

7.4.2 Europe

7.4.3 Asia-Pacific

7.4.5 Middle East & Africa

7.4.6 South America

8. Competitive Landscape

8.1 Mergers & Acquisition Analysis

8.2 Agreements, Collaborations, and Partnerships

8.3 New Products Launches

9. Key Players

9.1 Arthrex Inc.

9.2 Bioventus LLC

9.3 Depuy Synthes (A Subsidiary of Johnson & Johnson)

9.4 Globus Medical Inc.

9.5 Harvest Technologies Corporation (A Terumo BCT Company)

9.6 K2M Group Holdings Inc.

9.7 Kuros Biosciences Ltd.

9.8 Medtronic PLC

9.9 Nuvasive Inc.

9.10 Orthofix International N.V.

9.11 RTI Surgical Inc.

9.12 Seaspine Holdings Corporation

List not Exhaustive

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/nhq9dc/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190408005345/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Orthopedic Devices



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 04/08/2019 05:00 AM/DISC: 04/08/2019 05:00 AM